Read + Share

Amedeo Smart

Independent Medical Education


Read + Share

Taverna C, Martinelli G, Hitz F, Mingrone W, et al. Rituximab Maintenance for a Maximum of 5 Years After Single-Agent Rituximab Induction in Follicular Lymphoma: Results of the Randomized Controlled Phase III Trial SAKK 35/03. J Clin Oncol 2015 Dec 28. pii: JCO613968.
PMID: 26712227


Free Medical Abstracts
Privacy Policy
Sponsors
Share
About

© Amedeo 1997-2016